173 related articles for article (PubMed ID: 372246)
1. Marrow graft rejection and inhibition of growth in culture by serum in aplastic anaemia.
Barrett AJ; Faille A; Saal F; Balitrand N; Gluckman E
J Clin Pathol; 1978 Dec; 31(12):1244-8. PubMed ID: 372246
[TBL] [Abstract][Full Text] [Related]
2. Relevance of colony forming assays to bone marrow transplanation with particular reference to grafting for aplastic anaemia.
Gordon MY
Br J Haematol; 1979 May; 42(1):61-71. PubMed ID: 37884
[TBL] [Abstract][Full Text] [Related]
3. Bone-marrow transplantation in severe aplastic anaemia.
UCLA Bone Marrow Transplant Team
Lancet; 1976 Oct; 2(7992):921-3. PubMed ID: 62159
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia.
Storb R; Prentice RL; Thomas ED; Appelbaum FR; Deeg HJ; Doney K; Fefer A; Goodell BW; Mickelson E; Stewart P
Br J Haematol; 1983 Dec; 55(4):573-85. PubMed ID: 6231046
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Bone-marrow grafting for aplastic anaemia.
Lancet; 1975 Jan; 1(7897):22-3. PubMed ID: 46340
[No Abstract] [Full Text] [Related]
6. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
[TBL] [Abstract][Full Text] [Related]
7. [Bone marrow transplantation in severe aplastic anemia and acute leukemia].
Speck B; Sartorius J; Cornu P; Nissen C; Weber W; Gratwohl A
Onkologie; 1979 Apr; 2(2):79-82. PubMed ID: 42865
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic bone marrow transplantation in aplastic anemia--report of 25 cases.
Gluckman E; Devergie A; Marty M; Bussel A; Rottemboúrg J; Dausset J; Bernard J
Transplant Proc; 1978 Mar; 10(1):141-5. PubMed ID: 345552
[TBL] [Abstract][Full Text] [Related]
9. Marrow transplantation in thirty "untransfused" patients with severe aplastic anemia.
Storb R; Thomas ED; Buckner CD; Clift RA; Deeg HJ; Fefer A; Goodell BW; Sale GE; Sanders JE; Singer J; Stewart P; Weiden PL
Ann Intern Med; 1980 Jan; 92(1):30-6. PubMed ID: 6985782
[TBL] [Abstract][Full Text] [Related]
10. Sensitization against non-HLA antigens following bone marrow graft rejection.
Opelz G; Territo MC; Gale RP; Sparkes R
Tissue Antigens; 1977 Apr; 9(4):209-19. PubMed ID: 17932
[TBL] [Abstract][Full Text] [Related]
11. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection.
Storb R; Prentice RL; Thomas ED
N Engl J Med; 1977 Jan; 296(2):61-6. PubMed ID: 136605
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic stem cell transplantation in children with aplastic anemia.
Xue HM; Xu HG; Huang K; Guo HX; Li Y; Zhou DH; Huang SL; Fang JP; Chen C
Genet Mol Res; 2015 May; 14(2):5234-45. PubMed ID: 26125718
[TBL] [Abstract][Full Text] [Related]
13. Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group.
McCann SR; Bacigalupo A; Gluckman E; Hinterberger W; Hows J; Ljungman P; Marin P; Nissen C; van't Veer Kerthof E; Raghavachar A
Bone Marrow Transplant; 1994 Mar; 13(3):233-7. PubMed ID: 8199566
[TBL] [Abstract][Full Text] [Related]
14. Autologous marrow recovery and sensitization to non-HLA antigens after HLA-identical marrow transplantation for aplastic anemia.
Tsoi MS; Warren RP; Storb R; Witherspoon RP; Mickelson E; Giblett ER; Schanfield MS; Weiden P; Thomas ED
Exp Hematol; 1983 Jan; 11(1):73-81. PubMed ID: 6219886
[TBL] [Abstract][Full Text] [Related]
15. Immunological studies in patients with aplastic anemia who rejected marrow grafts from HLA-identical sibling donors.
Warren RP; Storb R; Thomas ED
Transplantation; 1982 Nov; 34(5):280-3. PubMed ID: 6760484
[TBL] [Abstract][Full Text] [Related]
16. Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival.
Storb R; Prentice RL; Thomas ED
J Clin Invest; 1977 Apr; 59(4):625-32. PubMed ID: 14972
[TBL] [Abstract][Full Text] [Related]
17. Correlation of the relative response index with marrow graft rejection in patients with aplastic anemia.
Mickelson EM; Fefer A; Storb R; Thomas ED
Transplantation; 1976 Sep; 22(3):294-302. PubMed ID: 135386
[TBL] [Abstract][Full Text] [Related]
18. Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia.
Niederwieser D; Pepe M; Storb R; Loughran TP; Longton G
Br J Haematol; 1988 May; 69(1):23-8. PubMed ID: 3289603
[TBL] [Abstract][Full Text] [Related]
19. Serum inhibitors of in vitro hematopoiesis and graft outcome in bone marrow transplantation for aplastic anemia.
Fitchen JH; Gale RP; Cline MJ
Transplantation; 1980 Mar; 29(3):223-6. PubMed ID: 6987787
[No Abstract] [Full Text] [Related]
20. Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
Hamblin M; Marsh JC; Lawler M; McCann SR; Wickham N; Dunlop L; Ball S; Davies EG; Hale G; Waldmann H; Gordon-Smith EC
Bone Marrow Transplant; 1996 May; 17(5):819-24. PubMed ID: 8733704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
